Indomethacin
NDC 85766-034, Indomethacin, capsule, extended release, from Sportpharm LLC.
- Product NDC
- 85766-034
- Status
- Listed
- Labeler
- Sportpharm LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201807
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85766-034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INDOMETHACIN75 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85766-034-00 | 85766003400 | 10 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-00) |
| 85766-034-01 | 85766003401 | 1 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-01) |
| 85766-034-02 | 85766003402 | 2 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-02) |
| 85766-034-06 | 85766003406 | 6 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-06) |
| 85766-034-07 | 85766003407 | 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-07) |
| 85766-034-10 | 85766003410 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-10) |
| 85766-034-14 | 85766003414 | 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-14) |
| 85766-034-20 | 85766003420 | 20 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-20) |
| 85766-034-30 | 85766003430 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-30) |
| 85766-034-60 | 85766003460 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-60) |
| 85766-034-90 | 85766003490 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85766-034-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/12821a3a-b5f2-4415-84c9-0a30a4725f1e
Use it
Look up 85766-034 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85766-034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85766-034. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.